AstraZeneca suspends tests of COVID-19 vaccine warning for a “Serious adverse reaction”.

The vaccine against COVID-19, produced by AstraZeneca in collaboration with Oxford University and Irbm of Pomezia (Italy) faced an unexpected stop. According to the pharmaceutical company, it is “a routine action” that occurs whenever there is a potential unexplained reaction in one of the tests.

AstraZeneca and COVID-19 vaccine: a serious adverse reaction caused the tests interruption 

The pharmaceutical company AstraZeneca has temporarily suspended all clinical trials on the COVID-19 vaccine, which it is developing in collaboration with the University of Oxford and Irbm in Pomezia after one of the trial participants experienced a serious potential adverse reaction.

According to AstraZeneca, it is “a routine action” that occurs whenever there is a potential unexplained reaction in one of the tests and that allows “to investigate and ensure at the same time the integrity of the test process is maintained”.

An unexpected stop that dampens the enthusiasm for an imminent solution to the tragedy of the coronavirus pandemic, but which, however, has the merit of bringing the direct issue back to the center: the seriousness of the tests on the COVID-19 vaccine.

Many scientists had looked with concern at the international “competition” for the synthesis of the vaccine, far from the scientific reliability usually expected. This stop seems to welcome and make their own those concerns, and prefer a lengthening of time to an unreliable production of this long-awaited and decisive vaccine.

READ THE ITALIAN ARTICLE

SOURCE

www.dire.it